...Thank you all so much for being here. And Lynelle, thank you so much for being here with us today. For those of you who don't know me, my name is Courtney Breen. I'm the large cap analyst here at Bernstein covering all of our US names, Bristol included. And I am very, very proud and happy to share the stage today with Lynelle here from Bristol. She is the Head of the Cell Therapy business. And we're going to have a bit of a conversation around -- particularly the potential in cell therapy, how it's landing in the hematology space, predominantly where it is today, where it might be going in the future. And so really, really excited to talk about this. Because I think we've got some proof points now, but there's a lot of innovation on the horizon, which is really, really exciting....
